Comparison of Short and Mid-Term Mortality and Morbidity in Patients With Severe Aortic Stenosis (Intermediate/High Risk) Who Underwent Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement

Yesiltas, Mehmet; Haberal, Ismail; Kuserli, Yusuf; YILDIZ, Ahmet; Koyuncu, Ahmet; Ozsoy, Sadiye

doi:10.1532/hsf.2913

Comparison of Short and Mid-Term Mortality and Morbidity in Patients With Severe Aortic Stenosis (Intermediate/High Risk) Who Underwent Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement

Copy For Citation

Yesiltas M. A., Haberal I., Kuserli Y., YILDIZ A., Koyuncu A. O., Ozsoy S. D.

HEART SURGERY FORUM, vol.23, no.2, 2020 (SCI-Expanded)

Publication Type: Article / Article
Volume: 23 Issue: 2
Publication Date: 2020
Doi Number: 10.1532/hsf.2913
Journal Name: HEART SURGERY FORUM
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Dokuz Eylül University Affiliated: No

Abstract

Treatment protocols for severe aortic valve stenosis include surgical aortic valve replacement (SAVR), balloon valvuloplasty, transcatheter aortic valve replacement (TAVR), and medical treatment. Because the success rates are getting higher with both SAVR and TAVR, making the right treatment decision is important.